Therefore, the inhibition of the PI3K/AKT/mTOR pathway may assist in eradicating leukaemia blasts, and there is ongoing work aimed at developing an inhibitor that will be useful in the clinic (as reviewed in Ref. Here, AKT1 is linked to leukemia.